Les données financières de cette entreprise sont partiellement disponibles (liasse simplifiée ou données confidentielles). Certaines sections ne sont pas affichées.

SNC PHARMACIE BOUC CAYOL : revenue, balance sheet and financial ratios

SNC PHARMACIE BOUC CAYOL is a French company founded 30 years ago, specialized in the sector Commerce de détail de produits pharmaceutiques en magasin spécialisé. Based in CANNES (06400), this company of category PME shows in 2024 a net income positive of 24 k€. Find below the complete financial statements, solvency ratios, working capital requirements and sector comparison.

Data updated on 2026-05-09

Sources : INPI & INSEE SIRENE - Processing : Ministry of Economy

Financial history - SNC PHARMACIE BOUC CAYOL (SIREN 402204283)
Indicator 2024 2023 2022 2021 2021 2020 2019
Revenue N/C N/C N/C N/C N/C N/C N/C
Net income 23 565 € 19 853 € 104 285 € 60 700 € 101 616 € 147 205 € 142 762 €
EBITDA N/C N/C N/C N/C N/C N/C N/C
Net margin N/C N/C N/C N/C N/C N/C N/C

Revenue and income statement

In 2024, SNC PHARMACIE BOUC CAYOL generates positive net income of 24 k€. Net income represents the final profit after all expenses (operating, financial, exceptional) and corporate tax. Change over 2019-2024: 143 k€ -> 24 k€.

Net income (2024) ?
Net income
Definition
Profit or loss after all expenses, including taxes and exceptional items.
Formula
Current income + Exceptional income - Income tax

23 565 €

Loading income statement...

Chart evolution

Show :

Assets

Loading data...

Liabilities

Loading data...

Solvency and debt ratios

The debt ratio (= Financial debt / Equity x 100) stands at 15%. This very low level reflects a solid financial structure, offering significant room for future investments or acquisitions. Financial autonomy (= Equity / Total assets x 100) reaches 62%. This high autonomy means the company finances most of its assets through equity, a sign of strength.

Debt ratio (2024) ?
Debt ratio
Definition
Measures the proportion of debt to equity.
Formula
(Financial debt / Equity) x 100
Interpretation
< 50% : Low
50-100% : Moderate
> 100% : High

14.836%

Financial autonomy (2024) ?
Financial autonomy
Definition
Share of equity in the company's total financing.
Formula
(Equity / Total assets) x 100
Interpretation
> 30% : Good autonomy
20-30% : Average
< 20% : Low

61.774%

Solvency indicators evolution
SNC PHARMACIE BOUC CAYOL

Sector positioning

Debt ratio
14.84 2024
2022
2023
2024
Q1: 16.46
Med: 58.47
Q3: 154.89
Excellent

In 2024, the debt ratio of SNC PHARMACIE BOUC CAYOL (14.84) ranks in the bottom 25% of the sector, which is positive. This ratio measures the weight of debt relative to equity. A low ratio indicates a solid financial structure with little dependence on creditors.

Financial autonomy
61.77% 2024
2022
2023
2024
Q1: 28.91%
Med: 49.95%
Q3: 69.47%
Good

In 2024, the financial autonomy of SNC PHARMACIE BOUC CAYOL (61.8%) ranks above the median of the sector. This ratio represents the share of equity in total financing. This comfortable position offers an appreciable safety margin.

Positioning of SNC PHARMACIE BOUC CAYOL in its sector

Comparison with sector Commerce de détail de produits pharmaceutiques en magasin spécialisé

Valuation estimate

Based on 225 transactions of similar company sales in 2024, the value of SNC PHARMACIE BOUC CAYOL is estimated at 328 984 € (range 229 099€ - 492 180€). This multiples method compares the actual sale price of similar companies to their financial indicators (Revenue, EBITDA, Net Income). It provides a market-based indicative estimate.

Estimated enterprise value 2024
225 transactions
229k€ 328k€ 492k€
328 984 € Range: 229 099€ - 492 180€
NAF 5 année 2024

Valuation method used

Net Income Multiple
23 565 € × 14.0x = 328 985 €
Range: 229 100€ - 492 180€

Only this financial indicator is available for this company.

Valuation evolution

How is this estimate calculated?

This estimate is based on the analysis of 225 actual transactions of similar company sales (same NAF code) registered with BODACC between 2016 and 2025.

  • EBITDA Multiple: Preferred method for profitable SMEs. EBITDA reflects the ability to generate cash.
  • Revenue Multiple: Used for growing companies or those with low profitability. Reflects commercial potential.
  • Net Income Multiple: Relevant for mature companies with stable results.

This estimate is provided for information purposes only. A precise valuation requires in-depth analysis (assets, liabilities, prospects, market...).

Similar companies (Commerce de détail de produits pharmaceutiques en magasin spécialisé)

Compare SNC PHARMACIE BOUC CAYOL with other companies in the same sector:

Voir toutes les statistiques du secteur Commerce de détail de produits pharmaceutiques en magasin spécialisé

Frequently asked questions about SNC PHARMACIE BOUC CAYOL

What is the revenue of SNC PHARMACIE BOUC CAYOL ?

The revenue of SNC PHARMACIE BOUC CAYOL is not publicly disclosed (confidential accounts filed with INPI).

Is SNC PHARMACIE BOUC CAYOL profitable?

Yes, SNC PHARMACIE BOUC CAYOL generated a net profit of 24 k€ in 2024.

Where is the headquarters of SNC PHARMACIE BOUC CAYOL ?

The headquarters of SNC PHARMACIE BOUC CAYOL is located in CANNES (06400), in the department Alpes-Maritimes.

Where to find the tax return of SNC PHARMACIE BOUC CAYOL ?

The tax return of SNC PHARMACIE BOUC CAYOL is available on this page. Click on a year in the 'Data by year' section to view the account details (assets, liabilities, income statement). Data comes from INPI (National Institute of Industrial Property).

In which sector does SNC PHARMACIE BOUC CAYOL operate?

SNC PHARMACIE BOUC CAYOL operates in the sector Commerce de détail de produits pharmaceutiques en magasin spécialisé (NAF code 47.73Z). See the 'Sector positioning' section above to compare the company with its competitors.